BioRestorative receives FDA Fast Track designation for BRTX-100 chronic lumbar disc disease program. News release. BioRestorative Therapies. February 20, 2025.

BioRestorative Therapies Inc (NASDAQ: BRTX) announced that the final subject in its BRTX-100 Phase 2 trial safety cohort has been dosed.

In October 2024, Dr. Cuéllar performed a three-level lumbar artificial disc replacement (ADR) using the ProDisc system. The procedure involved disc arthroplasty at the L3-4, L4-5, and L5-S1 levels.

In October 2024, Dr. Cuéllar performed a three-level lumbar artificial disc replacement (ADR) using the ProDisc system. The procedure involved disc arthroplasty at the L3-4, L4-5, and L5-S1 levels.

How we picked the best lumbar support pillows. To pick the best lumbar support pillows, we rounded up recommendations from experts, including chiropractors Dr. Matthew Cavanaugh and Dr. Allen Conrad.

(RTTNews) - BioRestorative Therapies, Inc. (BRTX) reported that the FDA has cleared an important amendment to the protocol of the ongoing phase 2 study investigating the use of BRTX-100, the lead ...

BioRestorative Therapies Inc (NASDAQ: BRTX) has announced that the independent Data Safety Monitoring Board (DSMB), overseeing the company's ongoing Phase 2 trial to treat chronic lumbar ...

VIVEX Biologics, Inc. sponsored research reports positive outcomes for patients with chronic lumbar discogenic pain treated using a single intradiscal injection of VIA Disc NP, an allogeneic ...

Lumbar RF sympatholysis can be conducted at the body of L3 classically or the lower part of L2. Multiple lesions can produce up to 75% relief for 8 weeks. [ 47 ] ...

Lumbar Extensor Training Improves Chronic Back Pain. January 10, 2013 . Direct Costs for Low Back Pain Care in U.K. Are Substantial An exercise regimen can improve ...